Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU divided on 1,3-D re-registration

A European Commission proposal not to re-register the nematicide, 1,3-dichloropropene (1,3-D), has failed to gain support from EU member states. At its meeting in July, the EU Standing Committee on the Food Chain and Animal Health could not reach the qualified majority required to accept or reject the proposal. The document will go to EU Ministers for a decision. Dow AgroSciences and Kanesho Soil Treatment re-applied for EU approval after the EU decided in 2006 not to re-register the ai. The Commission’s latest proposal against re-registration comes despite support from several member states for the active ingredient’s continued use, due to its role as an alternative to the ozone-depleting fumigant, methyl bromide ( Agrow No 575, p 15). Since the 2006 decision, several countries have exercised their right to allow emergency/exceptional uses to continue, with the most recent authorisation being in Spain (see this issue).

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG003453

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel